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Lamina Cribrosa Morphology 
Predicts Progressive Retinal Nerve 
Fiber Layer Loss In Eyes with 
Suspected Glaucoma
Jeong-Ah Kim1, Tae-Woo Kim  1, Robert N. Weinreb2, Eun Ji Lee1, Michaël J. A. Girard3,4 & 
Jean Martial Mari  5
Although early diagnosis and treatment reduce the risk of blindness from glaucoma, the decision on 
whether or not to begin treatment in patients with suspected glaucoma is often a dilemma because 
the majority of patients never develop definite glaucoma. A growing body of evidences suggests that 
posterior bowing of the lamina cribrosa (LC) is the earliest structural change preceding the retinal 
nerve fiber layer (RNFL) loss in glaucomatous optic neuropathy. Based on this notion, we conducted a 
prospective study enrolling 87 eyes suspected of having glaucoma to investigate whether the future 
rate of RNFL loss is associated with the baseline LC curve evaluated by measuring the LC curve index 
(LCCI) using enhanced depth imaging optical coherence tomography. A faster rate of RNFL loss was 
significantly associated with greater LCCI (P < 0.001;standardized coefficient beta = −0.392), older age 
(P = 0.008;beta = −0.314), and greater vertical cup-to-disc ratio (P = 0.040;beta = −0.233). Assessment 
of LC morphology may help predict the disease outcome in eyes with suspected glaucoma.
Glaucoma is an optic neuropathy characterized by progressive neuroretinal rim thinning, excavation, and loss 
of the retinal nerve fiber layer (RNFL). These structural changes are accompanied by irreversible functional loss, 
and structural damage often occurs earlier than a detectable visual field (VFD) defect1. In most studies, only a 
relatively small proportion of patients who were suspected of having glaucoma or who had disease-related risk 
factors, such as ocular hypertension, have been found to have definite glaucoma with a manifest VFD defect 
during follow-up2–5. Therefore, stratification of patients according to the likelihood of progression to glaucoma 
should facilitate better allocation of limited healthcare resources, allow for enhanced disease surveillance and 
earlier intervention for those at higher risk, and help avoid unnecessary interventions and treatment side effects 
in individuals deemed at low risk6.
Studies have shown that certain risk factors, such as older age, high intraocular pressure (IOP), thinner central 
cornea, disc hemorrhage (DH), and topographic optic disc measurements are predictive of the development of 
primary open-angle glaucoma among patients with suspected glaucoma or those with ocular hypertension7–11. 
Additionally, a visual field (VF) parameter (higher pattern standard deviation [PSD] of the Humphrey perim-
etry)9,10 and structural characteristics of the optic nerve (e.g., larger vertical and horizontal cup-to-disc [C/D] 
ratio or larger vertical C/D ratio asymmetry)9–11 have been shown to help predict eyes with a higher chance of 
developing definitive glaucomatous damage.
The lamina cribrosa (LC) is a mesh-like tissue composed of connective tissue, glial cells, and microvessels that 
support the axons of retinal ganglion cells (RGC)12,13. Experimental studies have shown that posterior displace-
ment of the LC precedes early surface-detected structural damage and RNFL loss14–17. Leung et al. demonstrated 
that the surface of the optic nerve head becomes depressed before RNFL thinning in patients with glaucoma18. 
1Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University 
Bundang Hospital, Seongnam, 13620, Republic of Korea. 2Shiley Eye Institute, Hamilton Glaucoma Center, 
Department of Ophthalmology, University of California, San Diego, 9500 Gilman Drive, La Jolla, California, 92093, 
USA. 3Department of Biomedical Engineering, National University of Singapore, Singapore, 117583 Singapore. 
4Singapore Eye Research Institute, Singapore National Eye Centre, 168751 Singapore, Singapore. 5GePaSud, 
University of French Polynesia, Faa’a, 98702 French Polynesia. Correspondence and requests for materials should be 
addressed to T.-W.K. (email: twkim7@snu.ac.kr)
Received: 16 August 2017
Accepted: 22 November 2017
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2SCIENtIfIC REPORTS | _ #####################_ | DOI:10.1038/s41598-017-17843-8
These findings suggest that LC deformation, such as posterior LC bowing that leads to an increase in LC curve 
and LC depth (LCD), may occur in the earliest stage of the disease, and that it may induce subsequent axonal 
damage. Based on these considerations, it has been proposed that evaluation of LC morphology is useful in pre-
dicting progression to manifest glaucoma among patients with suspected glaucoma.
The purpose of this study was to investigate whether LC morphology is predictive of the rate of RNFL thin-
ning among patients with suspected glaucoma.
Results
Baseline characteristics. One hundred two eyes of 102 patients with suspected glaucoma were initially 
included in the study. Of these, 3 patients had received IOP-lowering treatment before 3-year follow-up and, 
hence, were excluded from the study. Twelve subjects were also excluded because of the insufficient visibility of 
the anterior LC surface, leaving a final sample of 87 subjects. The subjects’ clinical characteristics are summarized 
in Table 1.
The patients were 56.6 ± 10.8 years old (range, 27–79 years) and 57 (62%) were female. Only three eyes (3.4%) 
among the 87 eyes were categorized as having ocular hypertension (OHT) at the baseline examination. The aver-
age number of OCT examinations per eye was 6.7 (range, 5–13) with an average follow-up time of 4.8 years. The 
entire cohort had a baseline IOP of 13.5 ± 3.2 mmHg (range, 7–24 mmHg), a refractive error (spherical equiv-
alent) of −0.40 ± 1.83 diopters (range, −6.13 to + 2.25 diopters), and a VF mean deviation of −0.13 ± 1.40 dB 
(range, −1.69 to 2.41 dB).
The 95% Bland-Altman limits of agreement between the measurements from the two glaucoma spe-
cialists were −23.18 to 23.36 µm for the LCD and −1.22 to 1.02 for the LCCI. Average LCD and LCCI were 
485.9 ± 107.3 µm (range, 242–709) and 7.93 ± 1.58 (range, 4.94–13.20), respectively. LCD was largest in the supe-
rior planes and gradually decreased when moving to the inferior region (plane 1, 2, 3 > 4 > 5, 6, 7), whereas 
the LCCI was largest in two most inferior planes, followed by the superior planes (plane 7, 6 > 1, 2, 3, 5 > 4) 
(P < 0.001, repeated measures ANOVA with Bonferroni’s post hoc test) (Fig. 1).
During follow-up, 6 DHs were detected in six patients (6.90%). Of these, 2 DHs were located in the superotem-
poral sector of the optic disc and the others were located in the inferotemporal sector. Of the 87 patients included 
in this study, 15 patients (17.24%) showed significant glaucoma progression and began to receive IOP-lowering 
treatment at 4.6 ± 1.3 years (range, 3 to 6 years) after baseline examination.
Variables Glaucoma suspect (n = 87)
Age (years) 56.36 ± 10.9 (27–79)
Female gender, (%) 54 (62.1)
Diabetes mellitus, (%) 16 (18.4)
Hypertension, (%) 25 (28.7)
Family history of glaucoma (%) 7 (8.0)
Cold extremities (%) 18 (20.7)
Migraine (%) 6 (6.9)
Baseline IOP (mmHg) 13.5 ± 3.2 (7–24)
Mean IOP during follow-up (mmHg) 13.3 ± 2.5 (7.5–20.9)
IOP fluctuation during follow-up (mmHg) 1.4 ± 0.6 (0–3.8)
Diagnosis (%)
  GON (n) 96.6% (84)
  OHT (n) 3.4% (3)
Refractive error (D) −0.40 ± 1.83 (−6.13 to +2.25)
Central corneal thickness (μm) 553.9 ± 37.8 (472–645)
Axial length (mm) 23.84 ± 1.07 (21.15–26.5)
Cup to disc ratio
Horizontal 0.62 ± 0.07 (0.5–0.8)
Vertical 0.60 ± 0.07 (0.4–0.8)
Global RNFL thickness (μm) 97.6 ± 9.4
Visual field MD (dB) −0.13 ± 1.40 (−1.69 to 2.41)
Visual field PSD (dB) 1.65 ± 0.40 (1.09–3.47)
Average LCD 485.9 ± 107.3 (242–709)
Average LCCI 7.93 ± 1.58 (4.94–13.20)
Disc hemorrhage during follow-up, (n) 8.1% (7)
Follow-up period (years) 4.8 ± 1.1 (3–6)
Number of SD-OCT RNFL scans 6.7 ± 2.0 (5–13)
Table 1. Demographic characteristics of the study subjects. IOP = intraocular pressure; GON = glaucomatous 
optic neuropathy; OHT = ocular hypertension; D = diopters; MD = mean deviation; PSD = pattern standard 
deviation; LCD = lamina cribrosa depth; LCCI = lamina cribrosa curvature index; RNFL = retinal nerve fiber 
layer; SD-OCT = spectral-domain optical coherence tomography. Data are mean ± standard deviation or n (%) 
values.
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Rate of RNFL loss. Figure 2 shows the mean rates of global and sectoral RNFL thickness loss over time. 
The rates of RNFL loss were −0.71 ± 0.56 μm/year in global (range, −2.29 to 0.20 μm/year), −1.38 ± 1.42 μm/
year in the inferior quadrant (range, −6.64 to 0.83 μm/year), and −0.65 ± 1.14 μm/year in the superior quad-
rant (range, −5.78 to 0.94 μm/year). Within-subject regional comparison of the rate of RNFL loss among the 
six sectors revealed that the rate was fastest in the inferotemporal sector followed by the superotemporal sector 
(−1.79 ± 1.89 and −1.13 ± 1.78 μm/year, respectively, P < 0.001). A significant inter-sectoral spatial correlation 
was found between the two sectors in the same horizontal planes; the rate of RNFL loss in the inferotemporal 
sector was significantly correlated with that in the inferonasal (r = 0.339, P = 0.001), but not with those in the 
inferonasal and inferotemporal sectors (r = 0.034, P = 0.752 and r = 0.067, P = 0.535, respectively). Likewise, the 
rate of RNFL loss in the superotemporal sector was significantly correlated with that in the superonasal sector 
(r = 0.254, P = 0.018), which had the same horizontal plane, but not with those in the inferonasal and inferotem-
poral sectors (r = 0.034, P = 0.752 and r = 0.067, P = 0.535, respectively).
Factors associated with the rate of RNFL loss. Factors associated with the rate of RNFL loss were 
determined using linear regression analysis. In the univariate analysis, older age (P = 0.038), higher baseline IOP 
(P = 0.045), greater vertical cup-to-disc (CD) ratio (P = 0.002), and larger average LCD (P = 0.004), and greater 
average LCCI (P < 0.001) were associated with a faster global RNFL loss. Multivariate analysis revealed that older 
age (P = 0.001, standardized coefficient beta = −0.314), greater vertical CD ratio (P = 0.013, beta = −0.233), 
and greater average LCCI (P < 0.001, beta = −0.392) were significant factors affecting the rate of global RNFL 
loss (Table 2, Fig. 3A). Although significant correlations were found between some variables (supplementary 
Table S1), the variance inflation factors (VIFs) for the variables to be included in the univariate analysis were less 
than 1.5 (data not shown).
A sub-analysis was performed to determine factors associated with the rate of RNFL loss rate in each of the 
superior and inferior sectors. Male gender (P = 0.016), greater vertical CD ratio (P = 0.015), and greater average 
LCCI of the superior-most two planes (P < 0.001) were associated with faster RNFL loss in the superior sector 
in univariate analysis. Of these factors, male gender (P = 0.042, beta = −0.220) and greater average LCCI of the 
superior-most two planes (P = 0.005, beta = −0.303) remained significantly associated with faster RNFL loss 
in the superior sector. In the inferior sector, older age (P = 0.023), presence of diabetes (P = 0.013), greater ver-
tical CD ratio (P = 0.029), larger average LCD of the inferior-most two planes (P = 0.003), and greater average 
LCCI of the inferior-most two planes (P < 0.001) were associated with faster RNFL loss in the univariate analysis. 
Figure 1. Lamina cribrosa depth (LCD, A) and lamina cribrosa curve index (LCCI, B) profiles in seven 
horizontal B-scan images (planes 1 and 7 correspond to the superior- and inferior-most planes, respectively) in 
eyes with suspected glaucoma. The LCD is largest in the superior planes and gradually decreases when moving 
to the inferior region. In contrast, the LCCI was greatest in inferior region followed by superior region.
Figure 2. Venn diagrams showing the rates of sectoral retinal nerve fiber layer thickness change over time 
(µm/year) in eyes with suspected glaucoma. The rate was fastest at the inferotemporal sector. G = global; 
IN = inferonasal; IT = inferotemporal; N = nasal; SN = superonasal; ST = superotemporal; T = temporal.
www.nature.com/scientificreports/
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Among these factors, older age (P = 0.008, beta = −0.239), greater vertical CD ratio (P = 0.040, beta = −0.184), 
and greater average LCCI of the inferior-most two planes (P < 0.001, beta = −0.512) remained significantly asso-
ciated with faster RNFL loss in the multivariate analysis (Table 2, Fig. 3A,B).
Spatial correlation between LCCI and rate of RNFL loss. In the within-subject regional compar-
ison (i.e., intra-eye comparison between the superior and inferior sectors), large variation was observed in 
terms of differences in regional LCCI difference. The difference in the LCCI between the average superior- and 
inferior-most two planes (i.e., the average LCCI of inferior-most two planes minus that of superior-most two 
planes) ranged from +6.52 to −5.47. In 56 (64.4%) subjects, the LCCI was greatest in the inferior-most two 
planes. In the remaining 31 (35.6%) patients, LCCI was greatest in the superior-most two planes. None of the 
subjects had the greatest LCCI in the mid-horizontal plane.
The sectoral rate of RNFL loss significantly corresponded with the LCCI at the corresponding region, i.e. the 
rate of RNFL loss was faster in the superior sector than in the inferior sector in eyes with a greater LCCI in the 
superior sector and vice versa (P = 0.006, Pearson’s chi-square test).
Spatial correspondence between LCCI and DH. Of the 6 patients who had DH, 2 had DH in the super-
otemporal sector and the remaining 4 in the inferotemporal sector. The inferior LCCI was larger than the supe-
rior LCCI in the 4 patients with inferotemporal DH. The 2 patients with superotemporal DH had larger LCCI 
superiorly.
Representative cases. Two representative cases showing the association between the LCCI and the rate of 
RNFL loss are presented in Fig. 4.
Variables
Global Superior sector Inferior sector
Univariate Multivariate Univariate Multivariate Univariate Multivariate
ß P ß P ß P ß P ß P ß P
Age, per 1-year older −0.012 0.038 −0.016 0.001 −0.012 0.263 −0.029 0.023 −0.028 0.008
Gender, female 0.141 0.26 0.586 0.016 0.518 0.042 −0.163 0.574
Diabetes mellitus −0.26 0.096 −0.07 0.445 −0.195 0.529 −0.882 0.013 −0.104 0.902
Hypertension 0.064 0.637 −0.036 0.892 0.236 0.447
Family history of glaucoma 0.32 0.151 0.397 0.369 0.916 0.074 0.02 0.88
Cold extremities 0.017 0.913 0.036 0.903 0.384 0.268
Migraine 0.181 0.452 0.151 0.751 0.837 0.129
Baseline IOP, mmHg −0.039 0.045 −0.32 0.052 −0.052 0.173 −0.073 0.1
Mean IOP during follow-up, mmHg −0.031 0.202 −0.05 0.301 −0.047 0.397
IOP fluctuation during follow-up, mmHg −0.140 0.140 −0.06 0.752 −0.285 0.195
Refractive error (spherical equivalent), diopters 0.024 0.482 0.102 0.122 0.005 0.95
Central corneal thickness, μm −0.001 0.777 −0.006 0.08 −0.13 0.228 0.001 0.835
Axial length, mm −0.02 0.749 −0.088 0.501 0.092 0.53
Visual field MD, dB −0.023 0.691 −0.026 0.805 0.033 0.795
Visual field PSD, 1dB 0.168 0.403 0.191 0.640 0.279 0.526
Cup to disc ratio
Horizontal −1.486 0.074 0.120 0.367 −3.059 0.062 −0.141 0.187 −0.345 0.071 −0.111 0.449
Vertical −2.651 0.002 −1.890 0.013 −4.174 0.015 −0.144 0.186 −4.385 0.029 −3.274 0.040
Baseline RNFL thickness, μm* 0.006 0.354 −0.002 0.742 −0.007 0.421
Number of SD-OCT scan −0.010 0.761 0.083 0.180 −0.122 0.087 −0.084 0.952
LCD†
Average of 7 planes −0.002 0.004 −0.033 0.797
Average of superior- most 2 planes −0.002 0.081 0.068 0.597
Average of inferior- most 2 planes −0.004 0.003 −0.025 0.530
LCCI†
Average of 7 planes −0.167 <0.001 −0.14 <0.001
Average of superior- most 2 planes −0.218 0.001 −0.192 0.005
Average of inferior- most 2 planes −0.354 <0.001 −0.328 < 0.001
Table 2. Factors associated with the rate of retinal nerve fiber layer thinning (n = 87). IOP = intraocular 
pressure; MD = mean deviation; PSD = pattern standard deviation; RNFL = retinal nerve fiber layer; 
LCD = lamina cribrosa depth; LCCI = lamina cribrosa curve index. *Baseline RNFL thickness means 
circumpapillary RNFL thickness at corresponding area. †The average values were defined as the mean values of 
the measurements from the 7 planes (from superior to inferior peripheral plane). Only variables with P < 0.1 on 
univariate analysis were included in the multivariate model. Values with statistical significance are in boldface.
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Discussion
Although lowering IOP treatment reduces the risk of glaucoma development in eyes with suspected glau-
coma, only a small proportion of patients with suspected glaucoma progress to definite glaucoma when left 
untreated3,19,20. Moreover, treatment-related side effects reduce the quality of life of patients21. Thus, the decision 
to initiate lowering IOP treatment in patients with suspected glaucoma should be based on the patient’s risk for 
developing visual loss to avoid unnecessary treatment. The present study found that the eyes with steeply curved 
LC lost RNFL more rapidly compared with eyes with a flat LC measurement among eyes with suspected glau-
coma. Considering that eyes with a faster rate of RNFL loss have a higher risk of developing VF loss in patients 
with suspected glaucoma22, the notion that steepness of the LC curve is associated with future rate of RNFL loss 
is clinically meaningful in regards of efficient prevention of glaucomatous VF loss.
Previous studies have demonstrated that LC deformation, which precedes the RNFL loss14,23,24, occurs as a 
posterior bowing15,17, Conversely, the LC curve becomes less curved after trabeculectomy in primary-open-angle 
glaucoma (POAG) patients25. Moreover, Lee et al. reported that LCCI had a diagnostic capability compa-
rable to RNFL thickness measurements to discriminate eyes with glaucoma from healthy eyes26. These find-
ings suggest that LC bowing is a characteristic feature of glaucoma and that LCCI is a valid parameter to assess 
glaucoma-associated LC deformity. For this reason, we used the LC curve index to assess the LC morphology in 
the present study.
The LCCI was measured using horizontal B-scan images. Because there is a horizontal ridge at or near the 
mid-horizontal optic nerve head (ONH)27, the LC is generally less displaced in this region in both healthy and 
glaucomatous eyes27. This results in a W-shaped configuration of the anterior LC surface in vertical and oblique 
scans (i.e., the LC would have at least two separate curvatures (Supplementary Video S1). Therefore, analysis of 
the LC configuration using vertical or oblique scans would be complicated. In contrast, LC has a relatively regular 
configuration in the horizontal plane with a flat or U shaped appearance with differing regional steepness, allow-
ing the measurement of LCCI (Supplementary Video S2).
The LCD was not associated with the rate of glaucoma progression in the multivariate analysis. This finding 
is likely to be related with its limitation as a parameter to represent the LC strain. Since the LCD was measured 
from Bruch’s membrane opening (BMO), it should be influenced by the choroidal thickness, which is known to 
be variable among individuals28. The LC is a sieve-like perforation in the posterior part of the sclera, which is 
sustained by load-bearing connective tissues of the peripapillary sclera. Therefore, the choroid is not relevant to 
the anteroposterior LC deformation. Thus, including the choroidal thickness in the LCD would lead to a biased 
assessment of LC morphology26. Our group previously reported that there is a substantial overlap for the LCD 
between healthy and glaucoma patients26.
There was a substantial variation among individual patients in the superior-inferior regional differences in the 
LCCI, and the rate of RNFL loss had a significant spatial correlation with the LCCI in the corresponding area of 
the ONH. These results suggest that LC deformation occurs with a regional difference between the superior and 
inferior hemi-optic nerve head, and that glaucomatous damage first develops in the region with more severely 
deformed LC. The spatial correlation between the rate of RNFL loss and LCCI supports the notion that LC defor-
mation is a key pathomechanism of glaucoma development and progression.
DH has been a known marker of rapid glaucoma progression29,30. However, we did not include DH as a covar-
iate in the current study. This was because the number of eyes with DH was too small to conduct a meaningful 
statistical analysis. In addition, some patients who were stable during the first two years were followed up only 
every 12 months thereafter. In such cases, there is a substantial possibility that DH may have been missed as DH 
typically lasts only 6–12 weeks31. Therefore, dividing the patients in the present study into DH positive and DH 
negative groups would be problematic.
There was a spatial correspondence between LCCI and DH. This finding may support that the DH may result 
from the disruption of capillaries within the laminar beams32. However, it cannot be ruled out that the observed 
spatial correspondence is simply an incidental finding due to small number of patients who had DH. Further 
study is needed to investigate the relationship between LCCI and DH.
IOP-related parameters are important factors for glaucoma progression33–35. However, none of IOP-related 
parameters were associated with the rate of RNFL thinning in the current study. This discrepancy may be the 
result of a relatively low baseline and average IOP during follow-up (13.5 ± 3.1 and 13.3 ± 2.5 mmHg, respectively) 
together with a low proportion of OHT (3.3%) in our subjects.
Figure 3. Scatterplots showing the relationship between the average (A) and superior (B) and inferior (C) 
lamina cribrosa curve index (LCCI) and the rate of retinal nerve fiber layer (RNFL) loss (µm/year). Significant 
relationships were observed both globally (A) and regionally (B,C) in the superior (B) and inferior (C) sectors.
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In the present study, we did not find a significant association between higher baseline PSD and increased 
risk of the glaucoma progression in contrast to earlier studies9,10,22. This may be attributed to differences in the 
study design and participants between studies. In particular, previous studies used the conversion to POAG as 
an outcome while we measured the rate of RNFL loss. PSD can also be an outcome for studies evaluating the VF 
change. Therefore, baseline PSD is more likely to be determined as a significant predictor for disease progression 
in a study based on VF testing. In addition, race of study participants and proportion of OHT patients among 
participant in our study are largely different from those in previous studies.
Although there was a significant tendency that eyes with larger LCCI had a fast rate of RNFL loss, there 
were a few patients who did not progress fast despite their large LCCI. The reason underlying this observation 
is unclear. One possible hypothesis is that the LC in those patients may be originally steeply curved from birth. 
Second, those patients may have some compensatory mechanisms that cancel the effect of LC strain at least partly. 
Another possibility is that, if followed over a longer period of time, those patients may have faster and significant 
slopes.
Figure 4. Representative cases. (A) A glaucoma suspect eye of a 61-year-old female with steeply curved 
lamina cribrosa (LC). The untreated intraocular pressure (IOP) and central corneal thickness were 16 mmHg 
and 537 µm, respectively. During the first 3 years following baseline examination, progressive retinal nerve 
fiber layer (RNFL) loss was observed in the inferior sector with the rate of −5.00 µm/year. After IOP-lowering 
treatment, the rate of RNFL loss decreased to −2.75 µm/year. (B) A glaucoma-suspected eye of a 74-year-old 
female with a relatively flat LC. The untreated IOP and central corneal thickness were 16 mmHg and 545 µm, 
respectively. During seven years of follow-up, the rate of RNFL loss in the inferior sector was −0.45 µm/year.
www.nature.com/scientificreports/
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The findings of this study should be considered in the light of some limitations. First, a LC surface reference 
line should be set from the LC insertion points to allow precise quantification of the LC curve. However, only the 
LC within the BMO width was included in measurement of the LC curve in the present study, since the LC was 
often not visible outside of this region. Furthermore, we previously demonstrated that the LCCI measured from 
the whole LC (between the LC insertions) was comparable with that measured on the LC within BMO in eyes 
with an LC visible up to the LC insertion25. Thus, we consider the assessment of the LC curve within BMO as a 
potential surrogate for assessment of the actual LC curve. Second, we referred to the change in the LC configura-
tion as a change in curvature; however, the curvature is a geometric entity that refers to the inverse of the radius of 
the arc of a circle best fitting the portion of the curve. Thus, it should be considered that the LCCI is not a param-
eter corresponding to an actual LC curvature and thus, further study is needed to investigate the method of cal-
culating the real curvature of LC. Third, eyes with a tilted or torted optic disc were excluded, and so the reported 
findings cannot be directly applied to eyes with such conditions. Forth, only patients who were followed-up for at 
least three years without IOP-lowering treatment were included. Thus, patients with rapid glaucoma progression, 
who needed IOP lowering treatment within three years after baseline examination, might have been excluded. 
However, only three patients from the original cohort were excluded due to IOP lowering treatment (data not 
presented). Thus, the influence of excluding those patients should be negligible. Fifth, this study only considered 
the LC curvature at baseline examination. Further study is needed to investigate whether LC curvature changes 
over time and to examine the influence of LC curvature changes on progressive RNFL loss. Lastly, all patients in 
this study were Korean. Therefore, the results of the present findings cannot be directly applied to other ethnic 
populations.
In conclusion, the steeply curved LC at baseline was associated with a faster rate of RNFL thinning in eyes with 
suspected glaucoma. These data suggest that assessment of LC morphology may be useful in predicting future 
disease progression in patients with suspected glaucoma.
Methods
This prospective study investigated the relationship between LC morphology and the rate of RNFL loss in patients 
with suspected glaucoma enrolled in the Investigating Glaucoma Progression Study (IGPS)36,37, which is an 
ongoing prospective study of glaucoma patients at the Glaucoma Clinic of Seoul National University Bundang 
Hospital Glaucoma Clinic. Written informed consent to participate was obtained from all subjects. This study was 
approved by the Seoul National University Bundang Hospital Institutional Review Board and conformed to the 
Declaration of Helsinki.
Study subjects. Patients enrolled in the IGPS underwent a complete ophthalmic examination including 
the following: measurement of best corrective visual acuity; refraction test; slit-lamp biomicroscopy; Goldmann 
applanation tonometry; gonioscopy; dilated stereoscopic examination of the optic disc; measurement of corneal 
curvature (KR-1800, Topcon, Tokyo, Japan), central corneal thickness (Orbscan II, Bausch & Lomb Surgical, 
Rochester, NY), and axial length (IOL Master version 5, Carl Zeiss Meditec, Dublin, CA, USA); stereo disc 
photography (EOS D60 digital camera, Canon, Utsunomiya-shi, Tochigi-ken, Japan); spectral-domain optical 
coherence tomography (SD-OCT; Spectralis OCT, Heidelberg Engineering, Heidelberg, Germany); and standard 
automated perimetry (Humphrey Field Analyzer II 750 and 24–2 Swedish interactive threshold algorithm; Carl 
Zeiss Meditec).
The IGPS excluded subjects with a history of intraocular surgery other than cataract extraction and glaucoma 
surgery, and intraocular disease (e.g., diabetic retinopathy or retinal vein occlusion) or a neurologic disease (e.g., 
stroke or brain tumor) that could cause VF loss, and best corrected visual acuities (BCVA) worse than 20/40.
All patients included in the IGPS were followed up every 3 to 6 months with regular follow-up slit-lamp examina-
tions using a 78-diopter lens or stereo disc photography, and SD-OCT RNFL thickness measured at intervals ranging 
from 6 months to 1 year. The present study enrolled only patients with suspected glaucoma on both eyes, and those 
with one eye with suspected glaucoma and the healthy fellow eye at baseline without any history of IOP-lowering 
treatment. Patients were required to undergo optic disc scan using EDI SD-OCT at baseline examination, and were 
untreated for at least 3 years with at least five serial SD-OCT RNFL thickness measurements. Eyes with suspected 
glaucoma were defined as those with OHT (IOP > 21 mmHg in the presence of a healthy-appearing optic disc and 
normal VF), a history of elevated IOP, or the appearance potential glaucoma on the optic disc (neuroretinal rim thin-
ning or RNFL defects on masked simultaneous stereophotograph assessments) in the presence of a normal VF at the 
time of SD-OCT imaging38. Glaucomatous appearance of the optic nerve was defined as (1) disc rim loss, notching 
or excavation; (2) cupping of the disc (C/D ratio > 0.6); (3) C/D ratio difference between fellow eyes > 0.2; (4) DH; 
or (5) diffuse or localized abnormalities of the RNFL, especially in the superior- and inferior-temporal regions. A 
glaucomatous VFD was defined as a defect fulfilling one or more of the following criteria: (1) outside normal limits 
on a glaucoma hemifield test, (2) three abnormal points with a P < 0.05 probability of being normal and one abnor-
mal point with P < 1% by PSD, or (3) a PSD of P < 5% confirmed on two consecutive reliable tests (fixation loss rate 
of ≤20% and false-positive and false-negative error rates of ≤25%).
The exclusion criteria were eyes with a BCVA worse than 20/40, a spherical equivalent of <−6.0 D or >+3.0 
D, a cylinder correction of <−3.0 D or >+3.0 D, a tilted (i.e., defined as a tilt ratio between the longest and short-
est diameters of the optic disc of >1.3)39,40, or a torted disc (i.e., defined as a torsion angle deviation of the long 
axis of the optic disc from the vertical meridian of >15°)40,41. Eyes were also excluded when a good-quality image 
(i.e., quality score >15) could not be obtained in more than five sections. When the quality score did not reach 15, 
the image-acquisition process automatically stopped, or images of the respective sections were not obtained. Only 
acceptable scans with a good-quality image that allowed clear delineation of the anterior border of the peripheral 
LC within the BMO were included to measure the LCD and the LCCI When both eyes of a patient satisfied the 
inclusion criteria, one eye was randomly chosen per subject.
www.nature.com/scientificreports/
8SCIENtIfIC REPORTS | _ #####################_ | DOI:10.1038/s41598-017-17843-8
During the follow-up period, IOP-lowering treatment was initiated when clinically meaningful progression 
was observed. Progression was defined as a structural (glaucomatous change confirmed by stereo optic disc, 
red-free RNFL photography, and/or SD-OCT) and/or functional development of reproducible glaucomatous 
VFD on SAP)42,43. In such cases, only data obtained during the untreated period were used for the analysis.
Baseline IOP was defined as the mean of at least two measurements at the baseline examination. Mean 
follow-up IOP was defined by averaging the IOPs measured at every visit and IOP fluctuation was determined 
using the standard deviation of these values.
A DH, defined as an isolated hemorrhage seen on the optic disc tissue or in the peripapillary retinal tissue 
connected to the optic disc rim, was detected by slit-lamp examination using a 78-diopter lens or stereo disc pho-
tography. One of these examinations was performed at every follow-up visit.
EDI-OCT of the optic disc and adaptive compensation to evaluate LC. The LCD and degree of LC curve 
(from flat to steeply curved shape) were measured using optic disc B-scan images25. The optic nerve image was obtained 
using the enhanced depth imaging (EDI) technique of the SD-OCT system, which was originally developed by Spaide 
et al.44. Prior to disc scan, the corneal curvature of each eye were entered into the Spectralis OCT system to avoid poten-
tial magnification errors. The optic disc was imaged through undilated pupils using a rectangle subtending 10°×15° of 
the optic disc. This rectangle was scanned with approximately 75 B-scan section images that were separated by 30–34 
μm (the distance between the scan line was determined automatically). Approximately 42 SD-OCT frames were aver-
aged for each section. This protocol provided the best trade-off between image quality and patient cooperation45.
To enhance the visibility of the anterior LC surface, all disc scan images were post-processed using adaptive 
compensation46–48, and the measurement was performed using a manual caliper tool in Amira software (version 
5.2.2, Visage Imaging, Berlin, Germany) by two experienced observers (JAK and TWK) who were masked to the 
clinical information. The average LCD and LCCI were determined as the mean values of the measurements made 
at seven points of the LC. Additionally, the average LCD and LCCI in the superior- and inferior-most two planes 
were used for intra-eye and inter-eye comparison according to the sector because the RGC axons in the superior 
and inferior quadrants pass through the uppermost two planes and lowermost two planes, respectively. The mean 
of the measurements from each of the two observers was used for analysis.
Measurement of LCD. The LCD was measured at the seven locations equidistant across the vertical optic 
disc diameter using horizontal SD-OCT B-scan images. These seven B-scan lines were defined as plane 1 to plane 
7 (superior to inferior regions, Fig. 5A) In this model, plane 4 corresponds to the mid-horizontal plane, and 
planes 2 and 6 correspond to the superior and inferior midperiphery, respectively. To determine the LCD, a line 
connecting the edges of BMO was set as a reference plane (BMO reference line), and then the LCD was measured 
in the direction perpendicular to the reference plane at the maximally depressed point (Fig. 5B).
Measurement of LC curve. The LC curve was assessed with the LCCI using baseline disc scan images. The 
method to calculate LCCI has been previously described25. In brief, LCCI was determined by measuring the width 
of the LC curve reference line (LCCW) and then measuring the LC curve depth (LCCD). The LCCW was defined 
as the width of the line connecting the two points on the anterior LC surface that met with lines drawn from each 
BMO termination point perpendicular to the BMO reference line. The maximum depth from the reference line to 
the anterior LC surface was defined as LCCD (Fig. 5C). The LCCI was calculated as (LCCD/LCCW) × 100. Since 
the curvature is normalized according to LC width, it describes the shape of the LC independent of the actual size 
of the ONH. Only the LC within the BMO was considered because the LC was often not clearly visible outside the 
BMO. In eyes with LC defects, the LCD and LCCI were measured using a presumed anterior LC surface that best 
fit the curvature of the remaining part of the LC or excluded the area of the LC defect.
The rate of progressive RNFL loss analysis. The RNFL thickness was measured using the parapap-
illary circle scan protocol of the Spectralis SD-OCT system (software version 5.4.7.0; Heidelberg Engineering, 
Heidelberg, Germany)49,50. The scan circle was centered on the center of the optic disc at baseline examination 
Figure 5. Measurement of the lamina cribosa depth (LCD) and lamina cribrosa curve index (LCCI) using 
B-scan images of the optic nerve head. (A) Infrared fundus image with lines pointing to the level of seven 
B-scan images spaced equidistantly across the vertical optic disc diameter in each eye. (B) The LCD was 
measured as the distance from the reference line connecting the two Bruch’s membrane opening (BMO) points 
to the anterior surface of the lamina cribrosa (LC). The LCD was measured at the maximally depressed point. 
(C) The LCCI was measured by dividing the LC curve depth (D) within the BMO by the width of the anterior 
LC surface reference line (W), and then multiplying by 100.
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and the follow-up scan was obtained automatically by a built-in automated realignment procedure (referred to as 
the ‘follow-up examination’ in the system documentation). Spectralis SD-OCT images measured from April 2009 
to August 2016 were included and the RNFL thickness measurements were estimated in four sectors separated 
into 90-degree intervals (superior, inferior, temporal, and nasal). Linear regression analysis against time was 
performed for the rates of global and RNFL loss in each sector for all subjects to determine the rate of RNFL loss 
(µm/year). The accuracy of the segmentation of the RNFL was reviewed, and segmentation errors were manually 
corrected by an experienced ophthalmologist (JAK) who was masked to the subjects’ clinical information.
Statistical analysis. The inter-observer agreement for measuring the LCCI and LCD was evaluated by cal-
culating the 95% Bland-Altman limits of agreement. A general linear model was used to investigate the factors 
associated with the rate of RNFL loss, first with a univariate model and then with a multivariate model that included 
variables from the univariate model for which P < 0.10. Correlations among the factors were assessed by calculating 
Spearman’s correlation coefficients. Collinearity between the variables was assessed by calculating the VIF. Repeated 
measures ANOVA was performed for within-subject regional comparison of the LCCI, LCD, and the rate of RNFL 
loss. The Pearson’s chi-square test was used to investigate the intra-eye influence of LCCI on the rate of RNFL loss 
by evaluation of the correspondence between the region with greater LCCI and the region with faster RNFL loss 
between the superior and inferior sectors. Probability values of P < 0.05 were considered statistically significant. 
Statistical analyses were performed using the Statistical Package for the Social Sciences software (version 22.0, SPSS, 
Chicago, IL, USA). The data are expressed as mean ± SD values except where stated otherwise.
Data availability. Data supporting the findings of this study are available within the article and its supple-
mentary information files and from the corresponding author on reasonable request.
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